Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis

Trial Profile

Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2017

At a glance

  • Drugs Losartan (Primary)
  • Indications Chronic bronchitis; Chronic obstructive pulmonary disease
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 16 Jun 2017 Planned End Date changed from 1 Feb 2018 to 1 May 2018.
    • 16 Jun 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Feb 2018.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top